{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:19:25Z","timestamp":1789705165335,"version":"4.0.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Microbiol Biotechnol"],"DOI":"10.1007\/s11274-026-04797-1","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T03:33:57Z","timestamp":1769139237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The rise of WHO-priority pathogens in central line associated bloodstream infection: Challenging the AWaRe paradigm in critical care"],"prefix":"10.1007","volume":"42","author":[{"given":"Gargee","family":"Anand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rijhul","family":"Lahariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4623-3523","authenticated-orcid":false,"given":"Ketan","family":"Priyadarshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"6","key":"4797_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/1348-0421.12887","volume":"65","author":"Y Akeda","year":"2021","unstructured":"Akeda Y (2021) Current situation of carbapenem-resistant Enterobacteriaceae and acinetobacter in Japan and Southeast Asia. Microbiol Immunol 65(6):229\u2013237","journal-title":"Microbiol Immunol"},{"issue":"8","key":"4797_CR2","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.3390\/antibiotics11081086","volume":"11","author":"D Alrahmany","year":"2022","unstructured":"Alrahmany D, Omar AF, Alreesi A, Harb G, Ghazi IM (2022) Acinetobacter baumannii Infection-Related mortality in hospitalized patients: risk factors and potential targets for clinical and antimicrobial stewardship interventions. Antibiotics 11(8):1086","journal-title":"Antibiotics"},{"key":"4797_CR3","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13756-023-01338-5","volume":"12","author":"MJ Alwazzeh","year":"2023","unstructured":"Alwazzeh MJ, Alnimr A, Al Nassri SA, Alwarthan SM, Alhajri M, AlShehail BM et al (2023) Microbiological trends and mortality risk factors of central line-associated bloodstream infections in an academic medical center 2015\u20132020. Antimicrob Resist Infect Control 12:128","journal-title":"Antimicrob Resist Infect Control"},{"key":"4797_CR4","doi-asserted-by":"crossref","unstructured":"Anand G, Lahariya R, Priyadarshi K, Sarfraz A (2025) Emerging threat of WHO priority pathogens in ICU-associated CLABSI and CAUTI: an integrated analysis of resistance patterns, epidemiological trends, and stewardship strategies. Acta Clin Belg 80(5):135\u2013145","DOI":"10.1080\/17843286.2025.2546420"},{"key":"4797_CR5","unstructured":"And C (2025) Global antimicrobial resistance and use surveillance system (GLASS) report \u2013\u20092022 [Internet]. Who.int. World Health Organization. [Cited 2025 Apr 29]. Available from: https:\/\/www.who.int\/publications\/i\/item\/global-antimicrobial-resistance-and-use-surveillance-system-(glass)-report-2022"},{"key":"4797_CR6","doi-asserted-by":"publisher","unstructured":"Appaneal HJ, Lopes VV, LaPlante KL, Caffrey AR (2022) Treatment clinical outcomes, and predictors of mortality among a national cohort of admitted patients with acinetobacter baumannii infection. Antimicrob Agents Chemother [Internet]. [Cited 2026 Jan 7]. Available from: https:\/\/doi.org\/10.1128\/aac.01975-21","DOI":"10.1128\/aac.01975-21"},{"key":"4797_CR7","unstructured":"Bacterial priority pathogen list (BPPL) [Internet]\u00a0(2017) REVIVE. [cited 2025 May 30]. Available from: https:\/\/revive.gardp.org\/resource\/bacterial-priority-pathogen-list\/?cf=encyclopaedia"},{"issue":"1","key":"4797_CR8","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1038\/s41598-023-51118-9","volume":"14","author":"MS Baek","year":"2024","unstructured":"Baek MS, Kim JH, Park JH, Kim TW, Jung HI, Kwon YS (2024) Comparison of mortality rates in patients with carbapenem-resistant enterobacterales bacteremia according to carbapenemase production: a multicenter propensity-score matched study. Sci Rep 14(1):597","journal-title":"Sci Rep"},{"issue":"2","key":"4797_CR9","first-page":"24","volume":"10","author":"R Bharti","year":"2024","unstructured":"Bharti R, Multani H, Sharma P, Sharma SS (2024) Causative organisms and associated antimicrobial resistance in central line-associated blood stream infections from patients admitted in ICU of tertiary health care hospital of Jammu region. Trop J Pathol Microbiol 10(2):24\u201330","journal-title":"Trop J Pathol Microbiol"},{"key":"4797_CR10","unstructured":"Bloodstream Infection Event (Central Line-Associated Bloodstream Infection and Non-central Line Associated Bloodstream Infection) [Internet]. [cited 2025 Jan 24]. Available from: https:\/\/www.cdc.gov\/nhsn\/PDFs\/pscManual\/4PSC_CLABScurrent.pdf?bcsi-ac-e0643eac7b939e3d=2325FF7500000002JFYeQSLbjK8VAWSm4pmXbJRbUICrHQAAAgAAAFRsbwCEAwAAPwAAAB3SCAA="},{"key":"4797_CR11","unstructured":"CDC Candida auris [Internet] (2024) Candida auris (C. auris). Cited 2024 Jun 14]. Available from: https:\/\/www.cdc.gov\/candida-auris\/index.html"},{"key":"4797_CR12","unstructured":"Centers for Disease Control and Prevention\u00a0(2024) Central line-associated bloodstream infection (CLABSI) basics [Internet]. CDC. Available from: https:\/\/www.cdc.gov\/clabsi\/about\/index.html"},{"key":"4797_CR13","unstructured":"Clinical & Laboratory Standards Institute [Internet] [cited 2025 Mar 27]. M100 Ed35 | Performance Standards for Antimicrobial Susceptibility Testing, 35th Edition. Available from: https:\/\/clsi.org\/standards\/products\/microbiology\/documents\/m100\/"},{"key":"4797_CR14","unstructured":"GLASS-FUNGI Module [Internet]. www.who.int. [Cited 2022 Feb 6]. Available from: https:\/\/www.who.int\/initiatives\/glass\/glass-modules-55"},{"key":"4797_CR15","doi-asserted-by":"crossref","unstructured":"Jacobs SE, Jacobs JL, Dennis EK, Taimur S, Rana M, Patel D et al (2022) Candida auris pan-drug-resistant to four classes of antifungal agents. Antimicrob Agents Chemother 30(7):e00053\u2013e00022","DOI":"10.1128\/aac.00053-22"},{"issue":"3","key":"4797_CR16","doi-asserted-by":"publisher","first-page":"e0282290","DOI":"10.1371\/journal.pone.0282290","volume":"18","author":"E Lafuente Cabrero","year":"2023","unstructured":"Lafuente Cabrero E, Terradas Robledo R, Civit Cu\u00f1ado A, Garc\u00eda Sardelli D, Hidalgo L\u00f3pez C, Giro Formatger D et al (2023) Risk factors of catheter- associated bloodstream infection: systematic review and meta-analysis. PLoS ONE 18(3):e0282290","journal-title":"PLoS ONE"},{"key":"4797_CR17","unstructured":"Lahariya MR, Anand G, Sarfraz A, Tiewsoh JBA, Kumar A (2025) CLABpredICU \u2013 AI-driven risk prediction for CLABSI in intensive care units based on clinical and biochemical parameters. Am J Infect Control [Internet]. May 28 [cited 2025 May 30]. Available from: https:\/\/www.sciencedirect.com\/science\/article\/pii\/S019665532500402X"},{"issue":"5","key":"4797_CR18","doi-asserted-by":"publisher","first-page":"799","DOI":"10.21037\/tp-2024-597","volume":"14","author":"L Li","year":"2025","unstructured":"Li L, Zheng Y, Deng W, Chen X, Lin S (2025) Central line-associated bloodstream infections in children: a systematic review and meta-analysis. Transl Pediatr 14(5):799\u2013811","journal-title":"Transl Pediatr"},{"issue":"1","key":"4797_CR19","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.ijmmb.2020.10.015","volume":"39","author":"P Mathur","year":"2021","unstructured":"Mathur P, Khurana S, Kumar S, Gupta D, Aggrawal R, Soni KD et al (2021) Device associated infections at a trauma surgical center of india: trend over eight years. Indian J Med Microbiol 39(1):15\u201318","journal-title":"Indian J Med Microbiol"},{"issue":"9","key":"4797_CR20","doi-asserted-by":"publisher","first-page":"e1317","DOI":"10.1016\/S2214-109X(22)00274-1","volume":"10","author":"P Mathur","year":"2022","unstructured":"Mathur P, Malpiedi P, Walia K, Srikantiah P, Gupta S, Lohiya A et al (2022) Health-care-associated bloodstream and urinary tract infections in a network of hospitals in india: a multicentre, hospital-based, prospective surveillance study. Lancet Glob Health 10(9):e1317\u2013e1325","journal-title":"Lancet Glob Health"},{"key":"4797_CR21","doi-asserted-by":"crossref","unstructured":"Mishra SK, Yasir M, Willcox M (2023) Candida auris: an emerging antimicrobial-resistant organism with the highest level of concern. Lancet Microbe 4(7):e482\u20133","DOI":"10.1016\/S2666-5247(23)00114-3"},{"key":"4797_CR22","doi-asserted-by":"crossref","unstructured":"Mosquera JMA, Assis Reveiz JK, Barrera L, Liscano Y (2024) Impact of central line-associated bloodstream infections on mortality and hospital stay in adult patients at a tertiary care institution in Cali, Colombia, 2015\u20132018. J Clin Med 11(18):5376","DOI":"10.3390\/jcm13185376"},{"issue":"3","key":"4797_CR23","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/antibiotics14030271","volume":"14","author":"A Rajandra","year":"2025","unstructured":"Rajandra A, Yunos NM, Teo CH, Kukreja A, Suhaimi NA, Mohd Razali SZ et al (2025) Incidence, Compliance, and risk factor associated with central Line-Associated bloodstream infection (CLABSI) in intensive care unit (ICU) patients: A multicenter study in an upper Middle-Income country. Antibiotics 14(3):271","journal-title":"Antibiotics"},{"issue":"12","key":"4797_CR24","doi-asserted-by":"publisher","first-page":"111367","DOI":"10.1016\/j.isci.2024.111367","volume":"27","author":"A Thacharodi","year":"2024","unstructured":"Thacharodi A, Vithlani A, Hassan S, Alqahtani A, Pugazhendhi A (2024) Carbapenem-resistant Acinetobacter baumannii raises global alarm for new antibiotic regimens. iScience 27(12):111367","journal-title":"iScience"},{"key":"4797_CR25","doi-asserted-by":"publisher","first-page":"S90","DOI":"10.1016\/j.eimc.2024.09.005","volume":"43","author":"M Urrea Ayala","year":"2025","unstructured":"Urrea Ayala M, Almendral A, Jordan Garc\u00eda I, Reyne Vergeli M, Porr\u00f3n R, Llad\u00f3 Maura Y et al (2025) Central line-associated bloodstream infections (CLABSI) in pediatric and neonatal intensive care units\u2014The VINCat program 2013\u20132022. Enfermedades Infecc Microbiol Cl\u00ednica 43:S90\u2013S97","journal-title":"Enfermedades Infecc Microbiol Cl\u00ednica"},{"key":"4797_CR26","unstructured":"Vital Signs Central Line\u2013Associated Blood Stream Infections --- United States, 2001, 2008, and 2009 [Internet]. [Cited 2025 May 14]. Available from: https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/mm6008a4.htm"},{"issue":"Supplement1","key":"4797_CR27","doi-asserted-by":"publisher","first-page":"S85","DOI":"10.1086\/518136","volume":"45","author":"RP Wenzel","year":"2007","unstructured":"Wenzel RP (2007) Health care\u2013associated infections: major issues in the early years of the 21st century. Clin Infect Dis 45(Supplement1):S85\u2013S88","journal-title":"Clin Infect Dis"},{"key":"4797_CR28","unstructured":"WHO bacterial priority pathogens list (2024) Bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance [Internet]. [cited 2025 Mar 26]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240093461"},{"key":"4797_CR29","unstructured":"WHO fungal priority pathogens list to guide research, development and public health action [Internet]. [cited 2025 Mar 26]. Available from: https:\/\/www.who.int\/publications\/i\/item\/9789240060241"},{"key":"4797_CR30","volume-title":"The WHO AWaRe (Access, Watch, Reserve) antibiotic book","author":"World Health Organization","year":"2022","unstructured":"World Health Organization (2022) The WHO AWaRe (Access, Watch, Reserve) antibiotic book. World Health Organization"},{"key":"4797_CR31","unstructured":"World Health Organization\u00a0(2022) WHO launches first ever global report on infection prevention and control [Internet]. World Health Organisation. Available from: https:\/\/www.who.int\/news\/item\/06-05-2022-who-launches-first-ever-global-report-on-infection-prevention-and-control"},{"key":"4797_CR32","unstructured":"World Health Organization\u00a0(2023) Antimicrobial Resistance [Internet]. World Health Organization. World Health Organization. Available from: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"4797_CR33","unstructured":"World Health Organization Report on the burden of endemic health care-associated infection worldwide (2011) Whoint [Internet]. [cited 2019 Jul 1]. Available from: http:\/\/apps.who.int\/iris\/handle\/10665\/80135"},{"key":"4797_CR34","unstructured":"Wright K (2025) Carbapenem-resistant infections rising across Europe [Internet]. European Medical Journal. [cited 2025 May 14]. Available from: https:\/\/www.emjreviews.com\/microbiology-infectious-diseases\/news\/carbapenem-resistant-infections-rising-across-europe\/"},{"issue":"4","key":"4797_CR35","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.jmii.2023.01.017","volume":"56","author":"M Zeng","year":"2023","unstructured":"Zeng M, Xia J, Zong Z, Shi Y, Ni Y, Hu F et al (2023) Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect 56(4):653\u2013671","journal-title":"J Microbiol Immunol Infect"},{"key":"4797_CR36","doi-asserted-by":"crossref","unstructured":"Zhang S, Di L, Qi Y, Qian X, Wang S (2024) Treatment of infections caused by carbapenem-resistant acinetobacter baumannii. Front Cell Infect Microbiol 14:1395260","DOI":"10.3389\/fcimb.2024.1395260"}],"container-title":["World Journal of Microbiology and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04797-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11274-026-04797-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11274-026-04797-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T10:30:54Z","timestamp":1773829854000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11274-026-04797-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":36,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,2]]}},"alternative-id":["4797"],"URL":"https:\/\/doi.org\/10.1007\/s11274-026-04797-1","relation":{},"ISSN":["1573-0972"],"issn-type":[{"value":"1573-0972","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"18 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was not required, as the study involved no direct patient contact or identifiable personal data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}],"article-number":"55"}}